BTIG downgrades Embecta stock rating on U.S. market share loss

🌐 Investing.com (CY) —
BTIG downgrades Embecta stock rating on U.S. market share loss

AI Summary

Embecta, a medical technology company, experiences a downgrade in stock rating due to a loss of market share in the U.S. This change reflects broader market dynamics affecting healthcare companies reliant on technology.

Markets Deals Health Embecta stock downgrade healthcare market share technology

Read original source →